Roche Seeks Avastin Breast Cancer Indication In Europe
This article was originally published in The Pink Sheet Daily
Marketing authorization application includes recent Phase III E2100 trial.
You may also be interested in...
Genentech is seeking a six-month priority review for bevacizumab in breast cancer.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Merger will create the leading generic injectable pharmaceutical company in the world.